<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Bullseye Biosciences — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
<header class="site-header"><h1>Prospect Detail</h1></header>
<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>43. Bullseye Biosciences</h1>
    <p class="meta">Therapeutic Protein Design</p>
  </div>
  <div class="section"><h3>1. Startup Name</h3><p><strong>Bullseye Biosciences</strong></p></div>
  <div class="section"><h3>2. Founder Contact</h3><p><strong>GSAS Team</strong> — Harvard Griffin Graduate School of Arts and Sciences</p></div>
  <div class="section"><h3>3. Product Overview</h3><p>Bullseye Biosciences is transforming therapeutic protein design to expedite the development of life-saving medicines. Using computational and experimental approaches, they optimize biologics for improved efficacy and manufacturability.</p></div>
  <div class="section"><h3>4. Funding Stage</h3><p><strong>Early Stage</strong> — PIC 2024 Finalist</p></div>
  <div class="section"><h3>5. How I Found the Company</h3><p>President's Innovation Challenge 2024 finalist announcements.</p></div>
  <div class="strengths-weaknesses">
    <div class="section"><h3>Strengths</h3><ul><li><strong>Platform potential:</strong> Protein design capabilities can address multiple disease areas.</li><li><strong>Harvard research access:</strong> Proximity to world-class structural biology and biochemistry labs.</li></ul></div>
    <div class="section"><h3>Weaknesses</h3><ul><li><strong>Capital intensive:</strong> Biotech drug development requires substantial funding.</li><li><strong>Long timelines:</strong> Years to clinical trials and potential revenue.</li></ul></div>
  </div>
  <div class="section"><h3>7. Five Questions for the Team</h3><ol class="questions-list"><li>What specific therapeutic areas are you targeting first?</li><li>What is your technology differentiation vs. other protein engineering platforms?</li><li>What pharma partnerships are you pursuing?</li><li>What is your IP strategy and current patent portfolio?</li><li>How much capital do you need to reach IND-enabling studies?</li></ol></div>
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>
</body>
</html>
